Syngenta’s bumper IPO will test Chinese appetite
Viewsroom
Reuters
4.4 • 58 Ratings
🗓️ 1 June 2023
⏱️ 17 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | AI is incredible. They can teach you how to fry an egg and even write a poem, pirate style. |
| 0:07.0 | But it knows nothing about your work. Slackbot is different. It doesn't just know the facts. It knows your schedule. |
| 0:15.0 | It can turn a brainstorm into a brief and it doesn't need to be taught. |
| 0:20.0 | Because Slackbot isn't just another AI. |
| 0:23.3 | It's AI that knows your work as well as you do. |
| 0:26.4 | Visit Slack.com forward slash meet Slackbot to learn more. |
| 0:30.3 | The views expressed on this podcast are those of the participants, not of Rourges News. |
| 0:57.0 | This is almost, you know, a poster trial, if you want, of China's ability to run foreign companies it has acquired, because it is true that, you know, Chinese players did manage to secure quite a bit of takeovers, you know, back in those years. But, you know, |
| 1:03.9 | there's been more recently a pushback. A test case of investor appetite for a company that reckons will help increase global food security will soon arrive on the Shanghai Stock Exchange. |
| 1:10.0 | Syngenta, a Swiss seeds-to-pesticides Maker, is planning a $9 billion listing. |
| 1:16.6 | The significance of this IPO for China and the rest of the world is the focus of this week's |
| 1:21.6 | Viewsroom. |
| 1:22.7 | Welcome back to the Views, a podcast from Reuters Breaking Views for columnists from around the |
| 1:27.4 | world talk about the big stories of the week. I'm your host, Amy Donnellan, coming back to the views room, a podcast from Reuters breaking views where columnists from around the world |
| 1:27.5 | talk about the big stories of the week. I'm your host, Amy Donnellin, coming to you from London. |
| 1:34.5 | Lamb of IPOs are a rare breed in this market, so there is much anticipation of Syngenta, a |
| 1:40.4 | seeds to pesticides maker that is planning a $9 billion listing in China. |
| 1:45.3 | It's been a long wait. |
| 1:46.9 | The process began two years ago, and there have been many twists and turns. |
| 1:51.5 | So here to talk to me about this fascinating saga is Yowin Chen, who's been covering the company, |
| 1:56.9 | as well as Lisa Yuka, our European business editor. |
| 2:06.5 | Thank you. as well as Lisa Yuka, our European business editor. Lisa and Yowant, you are very welcome to the newsroom. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Reuters, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Reuters and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

